⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27943909 | 0.97 | — | — | |
| Anthracene SCHEMBL28691619 | 0.78 | GRIN2D (0.34) | — | |
| SCHEMBL28407330 | 0.72 | — | — | |
| SCHEMBL9587810 | 0.69 | GSK3B (0.37) | — | |
| SCHEMBL684629 | 0.67 | — | — | |
| SCHEMBL6046966 | 0.67 | CA1 (0.34) | — | |
| SCHEMBL448198 | 0.67 | BACE1 (0.32) | — | |
| SCHEMBL2712453 | 0.66 | HAO1 (0.42) | — | |
| SCHEMBL16668754 | 0.65 | HSD17B3 (0.34) | — | |
| SCHEMBL11722468 | 0.65 | POLB (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731246-A2 | ALBUMIN BOUND MACROMOLECULE TRI-AGONIST ACTIVATING GLP-1/GIP/GLUCAGON RECEPTORS | AlbuNext, LLC (US) | 2026-04-29 | — | — | EP | claimed |
| US-12576141-B2 | Albumin bound macromolecule tri-agonist activating GLP-1/GIP/glucagon receptors | AlbuNext, LLC (US) | 2026-03-17 | — | — | US | claimed |
| US-20250312472-A1 | ANTIBODY COMPOUNDS WITH REACTIVE CYSTEINE AND RELATED ANTIBODY DRUG CONJUGATES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2025-10-09 | — | — | US | claimed |
| EP-4595982-A1 | MONOCONJUGATES AND THEIR PROCESS OF PREPARATION | Syndivia (FR) | 2025-08-06 | — | — | EP | claimed |
| EP-4596569-A1 | SITE SPECIFIC ANTIBODY DRUG CONJUGATES AND THEIR PROCESS OF PREPARATION | Syndivia (FR) | 2025-08-06 | — | — | EP | claimed |
| US-20250235404-A1 | PEG-LIPIDS AND LIPID NANOPARTICLES | CAPSTAN THERAPEUTICS, INC. | 2025-07-24 | — | — | US | claimed |
| EP-4504265-A1 | PEG-LIPIDS AND LIPID NANOPARTICLES | Capstan Therapeutics, Inc. (US) | 2025-02-12 | — | — | EP | claimed |
| US-20250042935-A1 | PHOTOCHEMICAL APPROACH TO C-TERMINAL A-AMIDATION | NOVO NORDISK A/S (DK) | 2025-02-06 | — | — | US | claimed |
| US-20250041439-A1 | ANTIBODY-DRUG CONJUGATES | SPIREA LIMITED (GB) | 2025-02-06 | — | — | US | claimed |
| WO-2025006503-A2 | ALBUMIN BOUND MACROMOLECULE TRI-AGONIST ACTIVATING GLP-1/GIP/GLUCAGON RECEPTORS | AlbuNext, LLC (US) | 2025-01-02 | — | — | WO | claimed |
| EP-3143154-A1 | CHEMICALLY-LOCKED BISPECIFIC ANTIBODIES | Sorrento Therapeutics, Inc. (US) | 2017-03-22 | — | — | EP | claimed |
| US-20160326266-A1 | Chemically-Locked Bispecific Antibodies | SORRENTO THERAPEUTICS, INC. (US) | 2016-11-10 | — | — | US | claimed |
| WO-2015175357-A9 | CHEMICALLY-LOCKED BISPECIFIC ANTIBODIES | SORRENTO THERAPEUTICS, INC. (US) | 2016-04-07 | — | — | WO | claimed |
| WO-2015175357-A1 | CHEMICALLY-LOCKED BISPECIFIC ANTIBODIES | SORRENTO THERAPEUTICS, INC. (US) | 2015-11-19 | — | — | WO | claimed |
| EP-2247589-A1 | 7-AZAINDOLE DERIVATIVES AS SELECTIVE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | Merck Patent GmbH (DE) | 2010-11-10 | — | — | EP | claimed |
| WO-2009059666-A1 | 7-AZAINDOLE DERIVATIVES AS SELECTIVE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | MERCK PATENT GMBH (DE) | 2009-05-14 | — | — | WO | claimed |
| EP-1390338-A1 | METHOD FOR OXIDISING HYDROCARBONS | Rhodia Polyamide Intermediates (FR) | 2004-02-25 | — | — | EP | claimed |
| WO-2002090309-A1 | METHOD FOR OXIDISING HYDROCARBONS | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2002-11-14 | — | — | WO | claimed |
| EP-1032557-A1 | METHOD FOR PREPARING BROMOMETHYL-BIPHENYL DERIVATIVES | SANOFI-SYNTHELABO (FR) | 2000-09-06 | — | — | EP | claimed |
| WO-1999025681-A1 | METHOD FOR PREPARING BROMOMETHYL-BIPHENYL DERIVATIVES | SANOFI-SYNTHELABO (FR) | 1999-05-27 | — | — | WO | claimed |